SMS Pharmaceuticals Share Price

₹ 504.15

-₹7.20 (-1.41%)
1D
Last updated 02 Nov, 2026, 15:59 IST
NSE: SMSPHARMA
|
Pharmaceuticals

SMS Pharmaceuticals Share Price Today

As of 3 Nov 2026, SMS Pharmaceuticals share price is ₹504.15. The stock opened at ₹511.00, compared to its previous close of ₹511.35. During today's trading session, SMS Pharmaceuticals share price moved in the range of ₹471.25 to ₹514.80, with an average price of ₹493.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹270.10 and a high of ₹525.00. On the performance front, SMS Pharmaceuticals share price has increased by 24.88% over the last six months and is up 76.47% on a year-on-year basis.

Share price over the last 1 day fell from 509.10 to 502.00, ranging between 478.35 and 509.65.
₹471.25
1.41% down today
₹514.80
1D LOW
1D HIGH

SMS Pharmaceuticals Stock Insights

Latest Earning
Op Profit TrendUp by 0.52% QoQ
Latest Earning
Net Profit TrendUp by 30.56% YoY
Latest Earning
Revenue TrendUp by 13.47% YoY
Stock Performance
OutperformingBeat Nifty by 5.38 % in last 1 month
Shareholding Pattern
DIIDII increased stake by 905.70%
Shareholding Pattern
FIIFII increased stake by 81.15%
SMS Pharmaceuticals stock performance
Open₹511.00
High₹514.80
Low₹471.25
Prev. close₹511.35
SMS Pharmaceuticals trading activity
Volume8,24,268
Average traded price₹497.38
Last traded time03:59:46 02 Nov
Last traded quantity3
Circuit
L
H
₹403.35
₹604.95
52-week
L
H
₹270.10
₹525.00
Mkt Cap Cr
4,792.64
P/E
46.82
P/B
6.1
ROA
6.57%
ROE
12.98%
ROCE
12.14%
Quick Ratio
0.81
EV/EBITDA
28.01

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
SMS Pharma. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
SMS Pharma. appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
SMS Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SMS Pharmaceuticals Company Background

ISIN
INE812G01025
Sector Market Cap
₹ 4,792.64 Cr

SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.

SMS Pharmaceuticals Financial Highlights

  • Revenue: SMS Pharmaceuticals reported revenue of ₹895.22 crore in FY26 vs ₹788.97 crore in FY25. It showed an increase of 13.47% on a yearly basis.
  • Operating Profit: SMS Pharmaceuticals reported an operating profit of ₹116.64 crore in FY26 vs ₹92.34 crore in FY25. It showed an increase of 26.32% on a year-on-year basis.
  • Net Profit: SMS Pharmaceuticals reported a net profit of ₹88.00 crore in FY26 vs ₹67.40 crore in FY25. It showed an increase of 30.56% on a yearly basis.

SMS Pharmaceuticals Quarterly Result Highlights

  • SMS Pharmaceuticals reported revenue of ₹208.70 crore in Jun 2026, compared with ₹240.52 crore in Mar 2026, representing a decrease of 13.23% on a quarter-on-quarter (QoQ) basis.
  • SMS Pharmaceuticals reported an operating profit of ₹27.21 crore in Jun 2026, compared with ₹27.07 crore in Mar 2026, representing an increase of 0.52% on a quarter-on-quarter (QoQ) basis.
  • SMS Pharmaceuticals reported a profit of ₹20.20 crore in Jun 2026, compared with ₹20.96 crore in Mar 2026, reflecting a decrease of 3.63% on a QoQ basis.
  • The earnings per share (EPS) of SMS Pharmaceuticals stood at ₹9.58 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
68.07%
FII
1.18%
Other DII
0.19%
Retail and other
30.56%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.04%
Mar 20260.31%
Jun 20260.65%
Sep 20261.18%

SMS Pharmaceuticals Investment Returns

1 day
-1.41%
1 week
+20.65%
1 month
+6.97%
1 year
+76.47%
3 years
+324.19%
5 years
+267.72%

SMS Pharmaceuticals Share Price History

SMS Pharmaceuticals share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹511.00 / ₹504.15
-1.41%
30 Oct 26
₹499.70 / ₹511.35
+5.26%
29 Oct 26
₹477.00 / ₹485.80
+2.18%
28 Oct 26
₹435.00 / ₹475.45
+7.37%
Show more

SMS Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹886.87₹782.75₹709.26₹522.05
Other Income₹8.35₹6.22₹4.46₹4.91
Total Revenue₹895.22₹788.97₹713.72₹526.97
Total Expenses₹778.59₹696.64₹647.62₹521.62
Profit Before Tax₹116.64₹92.34₹66.11₹5.35
Tax₹28.64₹24.94₹16.91₹1.47
Profit After Tax₹88.00₹67.40₹49.20₹3.88
EPS - Basic₹9.58₹8.16₹5.89-₹0.83
EPS - Diluted₹9.58₹8.16₹5.89-₹0.83

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹116.64₹92.34₹66.11₹5.35
Income before WC changes₹177.31₹144.62₹120.07₹58.34
Change in Assets-₹102.21-₹13.39-₹106.90-₹72.70
Change in Liabilities₹8.22-₹29.69₹52.35₹41.41
Change in WC-₹93.99-₹43.08-₹54.55-₹31.29
Cash flow from Operations₹59.22₹81.71₹50.12₹22.45
Cash flow from Investing-₹130.78-₹123.43-₹52.07-₹29.76
Cash flow from Financing₹76.03₹47.08₹30.68-₹31.97
Total Cash Flow₹4.48₹5.36₹28.73-₹39.28
Cash (Start of the year)₹41.40₹36.04₹7.31₹46.58
Cash (End of the year)₹45.88₹41.40₹36.04₹7.31

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹724.43₹598.21₹500.20₹468.96
Current Assets₹638.01₹554.47₹533.89₹410.65
Total Assets₹1,362.44₹1,152.68₹1,034.09₹879.61
Current Liabilities₹352.98₹324.37₹331.72₹254.91
Net Current Asset₹285.03₹230.10₹202.18₹155.74
Non-Current Liabilities₹223.65₹188.67₹166.05₹164.17
Equity Capital₹785.81₹639.64₹536.33₹460.53
Total Equity & Liabilities₹1,362.44₹1,152.68₹1,034.09₹879.61

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹886.87₹782.75₹709.26₹522.05
Other Income₹8.35₹6.22₹4.46₹4.91
Total Revenue₹895.22₹788.97₹713.72₹526.97
Total Expenses₹778.95₹695.65₹647.39₹521.42
Profit Before Tax₹116.27₹93.32₹66.33₹5.55
Tax₹28.66₹24.94₹16.91₹1.47
Profit After Tax₹87.61₹68.38₹49.42₹4.08
EPS - Basic₹9.58₹8.07₹5.84₹0.48
EPS - Diluted₹9.58₹8.07₹5.84₹0.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹116.27₹93.32₹66.33₹5.55
Income before WC changes₹177.49₹144.63₹120.07₹58.34
Change in Assets-₹100.86-₹13.39-₹106.90-₹72.70
Change in Liabilities₹8.15-₹29.69₹52.35₹41.41
Change in WC-₹92.71-₹43.08-₹54.55-₹31.29
Cash flow from Operations₹60.68₹81.71₹50.12₹22.45
Cash flow from Investing-₹132.33-₹123.44-₹52.07-₹29.76
Cash flow from Financing₹76.03₹47.08₹30.68-₹31.97
Total Cash Flow₹4.39₹5.35₹28.73-₹39.28
Cash (Start of the year)₹41.39₹36.04₹7.31₹46.58
Cash (End of the year)₹45.78₹41.39₹36.04₹7.31

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹744.43₹631.64₹534.36₹503.54
Current Assets₹636.57₹554.46₹533.89₹410.65
Total Assets₹1,381.00₹1,186.10₹1,068.25₹914.18
Current Liabilities₹352.54₹324.36₹331.72₹254.91
Net Current Asset₹284.03₹230.10₹202.18₹155.74
Non-Current Liabilities₹223.68₹188.67₹166.05₹164.17
Equity Capital₹804.79₹673.07₹570.49₹495.10
Total Equity & Liabilities₹1,381.00₹1,186.10₹1,068.25₹914.18
* All values are in INR Crore
SMS Pharmaceuticals market depth
Bid quantityBid priceAsk priceAsk quantity
00504.15171
0000
0000
0000
0000
Total bid quantity0
Total ask quantity171
SMS Pharmaceuticals technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
69.1
Neutral
ATR (14)
22.66
Neutral
STOCH(9,6)
88.63
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
29.05
Bearish
UO(9)
65.36
Neutral
ROC(12)
16.67
Bullish
WillR(14)
-11.37
Bearish
Period
Simple value
Exponential vaue
5D
466.65
476.4
10D
449.59
460.65
20D
450.29
451.59
50D
425.93
433.16
100D
405.1
415.6
Volume trend — traded volume by day
2 Nov8L
30 Oct43L
29 Oct5L
28 Oct7L
27 Oct3L
Average13L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SMS Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in SMS Pharmaceuticals

Fund name
AUM
quant Healthcare Fund
9.98%
Quant Small Cap Fund
0.26%
Bandhan BSE Healthcare Index Fund
0.08%

SMS Pharmaceuticals Returns Calculator

Ex-date: 22 Sep 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

SMS Pharmaceuticals Share Price FAQs

Please be aware that SMS Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.